Enovix (NASDAQ:ENVX - Free Report) had its price target reduced by B. Riley from $17.00 to $12.00 in a research note released on Tuesday,Benzinga reports. B. Riley currently has a buy rating on the stock.
ENVX has been the subject of several other reports. Cantor Fitzgerald restated an "overweight" rating and issued a $30.00 target price on shares of Enovix in a report on Thursday, February 20th. Benchmark dropped their target price on shares of Enovix from $25.00 to $15.00 and set a "buy" rating on the stock in a report on Tuesday, April 15th. JPMorgan Chase & Co. reduced their price objective on Enovix from $15.00 to $10.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Finally, Craig Hallum lowered their price objective on Enovix from $20.00 to $18.00 and set a "buy" rating on the stock in a research report on Thursday, February 20th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, Enovix presently has a consensus rating of "Moderate Buy" and an average target price of $17.27.
View Our Latest Analysis on Enovix
Enovix Price Performance
NASDAQ:ENVX traded up $0.29 during mid-day trading on Tuesday, reaching $6.43. 2,002,787 shares of the stock were exchanged, compared to its average volume of 6,212,755. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The business has a fifty day moving average price of $7.30 and a 200 day moving average price of $9.38. Enovix has a 1-year low of $5.27 and a 1-year high of $18.68. The firm has a market capitalization of $1.23 billion, a PE ratio of -4.44 and a beta of 1.98.
Enovix (NASDAQ:ENVX - Get Free Report) last released its earnings results on Wednesday, February 19th. The company reported ($0.17) EPS for the quarter, topping analysts' consensus estimates of ($0.18) by $0.01. The business had revenue of $9.72 million for the quarter, compared to the consensus estimate of $8.77 million. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%. Research analysts expect that Enovix will post -1.01 earnings per share for the current fiscal year.
Insider Activity at Enovix
In other Enovix news, CEO Rajendra K. Talluri sold 300,000 shares of the company's stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $9.35, for a total transaction of $2,805,000.00. Following the transaction, the chief executive officer now owns 2,045,301 shares of the company's stock, valued at approximately $19,123,564.35. This represents a 12.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 15.70% of the company's stock.
Institutional Trading of Enovix
Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in Enovix by 15.1% during the 4th quarter. Vanguard Group Inc. now owns 15,773,464 shares of the company's stock worth $171,458,000 after acquiring an additional 2,063,631 shares during the last quarter. Fred Alger Management LLC raised its holdings in Enovix by 212.4% in the fourth quarter. Fred Alger Management LLC now owns 1,838,914 shares of the company's stock worth $19,989,000 after purchasing an additional 1,250,300 shares during the period. Raymond James Financial Inc. bought a new position in shares of Enovix during the fourth quarter worth $3,484,000. Frontier Capital Management Co. LLC bought a new position in Enovix during the fourth quarter worth about $3,397,000. Finally, Geode Capital Management LLC increased its holdings in shares of Enovix by 6.6% in the fourth quarter. Geode Capital Management LLC now owns 3,818,827 shares of the company's stock worth $41,520,000 after acquiring an additional 235,142 shares in the last quarter. Institutional investors and hedge funds own 50.92% of the company's stock.
About Enovix
(
Get Free Report)
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
See Also

Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.